Difficulty: Medium
Average Score: 77%
Practice
In the empiric treatment of severe bacterial infections of unidentified etiology, this drug, often used in combination with an aminoglycoside, provides coverage against many staphylococci
Correct answer
D
Rationale
In this scenario, the correct answer is D) Nafcillin. Nafcillin is a penicillinase-resistant penicillin that provides coverage against many staphylococci, including methicillin-sensitive Staphylococcus aureus (MSSA). When treating severe bacterial infections of unidentified etiology, particularly those suspected to be caused by staphylococci, nafcillin is a preferred choice due to its efficacy against these pathogens.
Now, let's analyze why the other options are incorrect:
A) Amoxicillin: While amoxicillin is a commonly used antibiotic, it does not provide adequate coverage against many staphylococci, especially penicillinase-producing staphylococci.
B) Clavulanic acid: Clavulanic acid is a beta-lactamase inhibitor that is often combined with amoxicillin to enhance its spectrum of activity. It is not used on its own to provide coverage against staphylococci.
C) Erythromycin: Erythromycin is a macrolide antibiotic that is not typically used as a first-line treatment for severe bacterial infections caused by staphylococci. It is more commonly used for respiratory tract infections and skin infections.
Educational context: Understanding the appropriate antibiotic therapy for severe bacterial infections is crucial in clinical practice. Knowledge of the spectrum of activity, mechanisms of action, and resistance patterns of antibiotics is essential for healthcare professionals to make informed decisions when treating patients. In cases of severe bacterial infections where the pathogen is unidentified, selecting an empiric treatment with broad-spectrum coverage, like nafcillin for staphylococci, can be life-saving.
Now, let's analyze why the other options are incorrect:
A) Amoxicillin: While amoxicillin is a commonly used antibiotic, it does not provide adequate coverage against many staphylococci, especially penicillinase-producing staphylococci.
B) Clavulanic acid: Clavulanic acid is a beta-lactamase inhibitor that is often combined with amoxicillin to enhance its spectrum of activity. It is not used on its own to provide coverage against staphylococci.
C) Erythromycin: Erythromycin is a macrolide antibiotic that is not typically used as a first-line treatment for severe bacterial infections caused by staphylococci. It is more commonly used for respiratory tract infections and skin infections.
Educational context: Understanding the appropriate antibiotic therapy for severe bacterial infections is crucial in clinical practice. Knowledge of the spectrum of activity, mechanisms of action, and resistance patterns of antibiotics is essential for healthcare professionals to make informed decisions when treating patients. In cases of severe bacterial infections where the pathogen is unidentified, selecting an empiric treatment with broad-spectrum coverage, like nafcillin for staphylococci, can be life-saving.